Ribosome Inactivating Proteins, Type 1
"Ribosome Inactivating Proteins, Type 1" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Ribosome inactivating proteins consisting of only the toxic A subunit, which is a polypeptide of around 30 kDa.
| Descriptor ID |
D054789
|
| MeSH Number(s) |
D08.811.277.450.430.700.500 D12.776.765.710.500
|
| Concept/Terms |
|
Below are MeSH descriptors whose meaning is more general than "Ribosome Inactivating Proteins, Type 1".
Below are MeSH descriptors whose meaning is more specific than "Ribosome Inactivating Proteins, Type 1".
This graph shows the total number of publications written about "Ribosome Inactivating Proteins, Type 1" by people in this website by year, and whether "Ribosome Inactivating Proteins, Type 1" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1998 | 0 | 1 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Ribosome Inactivating Proteins, Type 1" by people in Profiles.
-
Phase 1 study of an anti-CD33 immunotoxin, humanized monoclonal antibody M195 conjugated to recombinant gelonin (HUM-195/rGEL), in patients with advanced myeloid malignancies. Haematologica. 2013 Feb; 98(2):217-21.
-
Single-chain antibody-based immunotoxins targeting Her2/neu: design optimization and impact of affinity on antitumor efficacy and off-target toxicity. Mol Cancer Ther. 2012 Jan; 11(1):143-53.
-
Biodistribution, pharmacokinetics, and nuclear imaging studies of 111In-labeled rGel/BLyS fusion toxin in SCID mice bearing B cell lymphoma. Mol Imaging Biol. 2011 Aug; 13(4):721-9.
-
Cytotoxic effects of basic FGF and heparin binding EGF conjugated with cytotoxin saporin on vascular cell cultures. J Surg Res. 1998 Feb 15; 75(1):35-41.
-
Elimination of malignant clonogenic T cells from human bone marrow using chemoimmunoseparation with 2'-deoxycoformycin, deoxyadenosine and an immunotoxin. Bone Marrow Transplant. 1990 Jun; 5(6):395-402.